Skip to content

Solid Biosciences Inc. SLDB Prepaid & Other Current

Prepaid & Other Current at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$187.97M+78.2%
Biogen logo
BiogenBIIB
$1.17B+54.3%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$27.5M-76.9%
Insmed logo
InsmedINSM
$78.2M+42.7%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$48.87M+307%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$5.23M+42.5%

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Market cap$872.26M+135%
Enterprise value$595.83M+223%
P/S107.8×-9.9×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s prepaid & other current?
Solid Biosciences Inc. (SLDB) reported prepaid & other current of $15.47M in Q1 2026.
How has Solid Biosciences Inc.'s prepaid & other current changed year-over-year?
Solid Biosciences Inc.'s prepaid & other current increased by 138.3% year-over-year, from $6.49M to $15.47M.
What is the long-term trend for Solid Biosciences Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Solid Biosciences Inc.'s prepaid & other current has grown at a 31.6% compound annual growth rate (CAGR), from $4.16M to $16.38M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.